Gastrointestinal Physiology And Motility - USMLE Step 1

SECTION 1

Historical Context & Motivation

The study of gastrointestinal motility traces its origins to early observations that the gut is not merely a passive tube but a dynamically regulated organ system. Understanding how luminal contents are propelled, mixed, and ultimately absorbed has been central to both basic physiology and clinical medicine. From the discovery of the enteric nervous system to the molecular characterization of interstitial cells of Cajal, each advance has transformed our ability to diagnose and treat motility disorders—conditions that affect millions of patients worldwide and appear frequently on the USMLE Step 1 examination.

1833 • Beaumont's Gastric Observations

William Beaumont published observations from Alexis St. Martin's gastric fistula, providing the first systematic study of gastric motility and secretion in vivo.

1899 • Bayliss & Starling — The Law of the Intestine

Bayliss and Starling described the peristaltic reflex—contraction orad and relaxation aborad to a bolus—establishing the concept of intrinsic gut reflexes independent of extrinsic innervation.

1921 • Alvarez & Electrical Slow Waves

Walter Alvarez recorded rhythmic electrical activity from the GI smooth muscle, laying groundwork for the concept of slow waves and the basic electrical rhythm of the gut.

1982 • Interstitial Cells of Cajal as Pacemakers

Research confirmed that interstitial cells of Cajal (ICCs) serve as GI pacemaker cells, generating the slow-wave electrical activity that coordinates smooth muscle contraction throughout the tract.

2000s • High-Resolution Manometry & Molecular Era

High-resolution manometry and identification of c-Kit receptor expression on ICCs revolutionized diagnosis of motility disorders and clarified the molecular basis of GI pacemaking.

These historical advances converge on a fundamental question: how does the gastrointestinal tract coordinate the movement of ingested material from mouth to anus with precisely timed secretion, digestion, and absorption? Answering this question requires an integrated understanding of smooth muscle electrophysiology, the enteric nervous system, hormonal regulation, and the specific motility patterns unique to each GI segment—a framework that is essential for clinical reasoning and board preparation.

SECTION 2

Core Principles of GI Motility

GI motility is governed by the interplay of four major systems: the intrinsic smooth muscle properties, the enteric nervous system (ENS), the autonomic nervous system (ANS), and gastrointestinal hormones. The smooth muscle of the GI wall is arranged in two principal layers: an inner circular layer and an outer longitudinal layer, separated by the myenteric (Auerbach) plexus. Interstitial cells of Cajal, positioned between nerve terminals and smooth muscle cells, generate rhythmic depolarizations known as slow waves that set the maximum frequency of contraction for each GI segment. Whether a contraction actually occurs depends on whether the slow wave reaches threshold and triggers spike potentials (action potentials) superimposed on the slow wave plateau, a process modulated by neural and hormonal input.

Slow Waves & ICCs

Interstitial cells of Cajal generate cyclical depolarizations (slow waves) that determine the maximal contraction frequency. Slow waves alone do not cause contraction; spike potentials must be superimposed.

Enteric Nervous System

The ENS—sometimes called the 'little brain'—contains ~100 million neurons organized into the myenteric (Auerbach) plexus controlling motility and the submucosal (Meissner) plexus regulating secretion and blood flow.

Peristalsis & Segmentation

Peristalsis propels contents aborally via orad contraction and caudal relaxation. Segmentation involves alternating ring contractions that mix contents without net propulsion—dominant in the small intestine during digestion.

Autonomic Modulation

Parasympathetic (vagus, pelvic nerves) input generally enhances motility via ACh on muscarinic receptors. Sympathetic input (splanchnic nerves) generally inhibits motility via norepinephrine on α and β adrenergic receptors.

GI Hormones

Motilin triggers the migrating motor complex (MMC) during fasting. Cholecystokinin (CCK) stimulates gallbladder contraction and slows gastric emptying. Gastrin increases gastric motility. GIP and secretin inhibit gastric motility.

✦

KEY TAKEAWAY

Think of the GI tract like a concert orchestra. The interstitial cells of Cajal are the conductor, setting the tempo (slow waves). The smooth muscle cells are the musicians—they can only play (contract) when the conductor's beat reaches the right intensity (threshold for spike potentials). The enteric nervous system is the sheet music, providing the programmed pattern of contraction. The autonomic nervous system is the audience—applause (parasympathetic) makes the performance louder, while a quiet audience (sympathetic) dampens the output. No single element works in isolation; coordinated motility requires all four systems operating in concert.

SECTION 3

Visual Explanation — Slow Waves, Spike Potentials & Motility Patterns

Upper panel: slow waves (cyan) oscillate the resting membrane potential but do not reach threshold alone. When neural or hormonal stimuli bring the slow wave above threshold, spike potentials (pink) fire and produce muscle contraction. Lower panel: the intrinsic slow wave frequency decreases from duodenum (12/min) to colon (2–6/min), with the stomach at approximately 3/min.

The upper panel of the diagram illustrates the fundamental electrophysiology of GI smooth muscle. At rest, smooth muscle cells maintain a resting membrane potential of approximately −50 to −60 mV, though this varies by region. Slow waves generated by ICCs produce cyclical depolarizations and repolarizations that bring the membrane potential toward, but not necessarily past, the threshold for contraction. When neurohumoral input (e.g., acetylcholine from parasympathetic fibers) depolarizes the cell further, the slow wave crosses threshold and spike potentials are generated. These spike potentials open voltage-gated Ca²⁺ channels, allowing calcium influx that triggers smooth muscle contraction via the calmodulin–myosin light-chain kinase (MLCK) pathway. The lower panel emphasizes a high-yield board concept: slow wave frequencies differ by GI region, and these frequencies set the maximum possible contraction rate for each segment.

SECTION 4

Mechanisms of GI Smooth Muscle Contraction

GI smooth muscle contraction follows a distinct molecular pathway compared to skeletal muscle. Rather than relying on troponin, smooth muscle contraction is regulated by the calcium–calmodulin–MLCK pathway. When intracellular Ca²⁺ rises—either through voltage-gated L-type calcium channels during spike potentials or via IP₃-mediated release from the sarcoplasmic reticulum—calcium binds to calmodulin. The Ca²⁺–calmodulin complex activates myosin light-chain kinase, which phosphorylates the 20-kDa regulatory light chain of myosin II, enabling cross-bridge cycling with actin. Relaxation occurs when myosin light-chain phosphatase (MLCP) dephosphorylates the light chain, and Ca²⁺ is sequestered back into the SR by SERCA pumps or extruded by Na⁺/Ca²⁺ exchangers.

SMOOTH MUSCLE CONTRACTION CASCADE

Ca²⁺ + Calmodulin → Ca²⁺–CaM → activates MLCK → phosphorylates MLC₂₀ → cross-bridge cycling → CONTRACTION

Ca²⁺ = intracellular calcium; CaM = calmodulin; MLCK = myosin light-chain kinase; MLC₂₀ = 20 kDa regulatory myosin light chain. Relaxation requires MLCP-mediated dephosphorylation and Ca²⁺ removal.

Neural Modulation of Motility

The myenteric (Auerbach) plexus lies between the longitudinal and circular muscle layers and primarily controls motility. It contains excitatory motor neurons releasing acetylcholine (ACh) and substance P to stimulate contraction, and inhibitory motor neurons releasing nitric oxide (NO) and vasoactive intestinal peptide (VIP) to promote relaxation. The submucosal (Meissner) plexus primarily governs secretion and local blood flow. Extrinsic parasympathetic input (vagus nerve above the splenic flexure; pelvic nerves below) enhances ENS activity and promotes motility, while sympathetic input via splanchnic nerves inhibits motility by reducing ACh release from enteric neurons and by directly relaxing smooth muscle via β₂-adrenergic receptors or constricting sphincters via α₁ receptors.

Hormonal Regulation

Hormone	Source	Effect on Motility	Additional Notes
Motilin	Duodenal M cells	↑ Initiates migrating motor complex (MMC) during fasting	Erythromycin is a motilin receptor agonist (prokinetic)
Gastrin	Antral G cells	↑ Gastric motility; relaxes ileocecal valve	Stimulated by stomach distension, vagal input, amino acids
CCK	Duodenal/jejunal I cells	↑ Gallbladder contraction; ↓ gastric emptying	Stimulated by fatty acids and amino acids in duodenum
Secretin	Duodenal S cells	↓ Gastric motility and acid secretion	Stimulated by H⁺ in duodenum
GIP	Duodenal/jejunal K cells	↓ Gastric motility and acid secretion	Also known as glucose-dependent insulinotropic peptide (incretin)

Key GI hormones and their effects on motility

SECTION 5

Motility Patterns by GI Region

Each segment of the GI tract exhibits distinctive motility patterns adapted to its physiological function. Understanding the specific motor activities of the esophagus, stomach, small intestine, and colon is essential for both clinical reasoning and USMLE preparation, as pathological disruption of these patterns underlies common disorders such as achalasia, gastroparesis, ileus, and irritable bowel syndrome.

Comprehensive overview of regional motility patterns and key GI reflexes. The upper row details the dominant motility pattern for each major GI segment—from esophageal peristalsis to colonic mass movements. The lower panels summarize five clinically important reflexes that coordinate inter-segmental motility.

Esophageal Motility

Swallowing initiates primary peristalsis, a coordinated wave that propels the bolus from pharynx to stomach in 8–10 seconds. The upper esophageal sphincter (UES), composed of striated muscle (cricopharyngeus), relaxes as the swallowing center in the medulla coordinates pharyngeal contraction. The upper third of the esophageal body contains striated muscle innervated by the vagus nerve (nucleus ambiguus); the lower two-thirds transitions to smooth muscle innervated via the dorsal motor nucleus of the vagus. The lower esophageal sphincter (LES) maintains tonic contraction at rest to prevent gastric reflux and relaxes during swallowing via VIP and NO released from inhibitory enteric neurons. Secondary peristalsis is triggered by local distension from residual food and occurs without a voluntary swallow. In achalasia, loss of inhibitory ganglion cells in the myenteric plexus leads to failure of LES relaxation and aperistalsis of the esophageal body—a classic USMLE topic.

Gastric Motility

The stomach serves as both a reservoir and a mixer. The proximal stomach (fundus and upper body) exhibits receptive relaxation (a vagovagal reflex mediated by VIP and NO) that allows accommodation of up to 1.5 liters without a significant rise in intraluminal pressure. The distal stomach (antrum) generates powerful peristaltic contractions at a frequency set by the gastric slow wave of approximately 3 cycles per minute. Antral peristalsis propels chyme against a closed pylorus, which causes retropulsion—the backward squirting of food that further grinds particles to less than 2 mm before they can pass through the pylorus. Gastric emptying is regulated by both neural (vagovagal) and hormonal (CCK, secretin, GIP) feedback from the duodenum; fat and hyperosmolar contents in the duodenum slow emptying the most. Clinically, gastroparesis (delayed gastric emptying, often due to diabetic vagal neuropathy) presents with nausea, early satiety, and vomiting of undigested food.

Small Intestinal & Colonic Motility

In the fed state, the small intestine primarily exhibits segmentation, a pattern of alternating ring contractions that mixes chyme with pancreatic enzymes and bile without significant net propulsion, maximizing mucosal contact time for absorption. During fasting, the migrating motor complex (MMC) sweeps undigested material and bacteria aborally in ~90-minute cycles. The MMC has three phases: Phase I (quiescence, ~45 min), Phase II (irregular contractions, ~30 min), and Phase III (intense regular contractions, ~5–10 min). Phase III is initiated by motilin and is sometimes called the 'housekeeper' of the gut because it clears residual debris and bacteria, preventing small intestinal bacterial overgrowth (SIBO). The colon primarily performs haustral churning to mix and absorb water, with periodic mass movements (1–3 times per day) that propel fecal material toward the rectum. The gastrocolic reflex, triggered by eating, increases colonic motility and often produces the urge to defecate after a meal.

SECTION 6

Worked Example — Clinical Reasoning in GI Motility

The following clinical vignette demonstrates how knowledge of GI motility physiology applies to a USMLE-style question.

Clinical Vignette: 35-Year-Old with Progressive Dysphagia

1
Step 1 — Read the Stem

A 35-year-old woman presents with progressive dysphagia to both solids and liquids over the past 6 months. She reports regurgitation of undigested food, especially when lying flat at night. A barium swallow shows a dilated esophagus with a smooth, tapered 'bird's beak' narrowing at the gastroesophageal junction. Esophageal manometry reveals absent peristalsis in the esophageal body and failure of LES relaxation upon swallowing. What is the underlying pathophysiology?
2
Step 2 — Identify Key Clinical Features

The dysphagia is to both solids AND liquids from the outset—this pattern indicates a motility disorder rather than a mechanical obstruction (which typically presents first with solids, then liquids). The bird's beak appearance on barium swallow and the manometric findings of absent peristalsis with non-relaxing LES are classic for achalasia.

Key clue: dysphagia to both solids and liquids = motility disorder
3
Step 3 — Apply Physiological Knowledge

Normal LES relaxation during swallowing is mediated by inhibitory neurons in the myenteric (Auerbach) plexus that release VIP and NO. In achalasia, there is a selective loss of these inhibitory ganglion cells. Without inhibitory input, the LES remains tonically contracted, and the esophageal body loses the coordinated peristaltic wave needed to propel food. Excitatory cholinergic neurons are relatively spared, which contributes to the unopposed LES contraction.

Pathophysiology: loss of inhibitory ganglion cells (VIP/NO-releasing neurons) in the myenteric plexus
4
Step 4 — Consider Differential and Treatment

In South America, always consider Chagas disease (Trypanosoma cruzi) as a cause of secondary achalasia, since the parasite destroys myenteric ganglia. Treatment options include pneumatic dilation, Heller myotomy, or per-oral endoscopic myotomy (POEM). Pharmacologically, calcium channel blockers and nitrates can provide temporary LES relaxation. Botulinum toxin injection into the LES inhibits ACh release from the excitatory neurons that maintain LES contraction.

Answer: Achalasia due to loss of inhibitory myenteric plexus neurons → failure of LES relaxation and aperistalsis

SECTION 7

Clinical Correlations & Pharmacological Targets

GI motility disorders represent a significant portion of clinical gastroenterology and appear frequently on board examinations. Understanding the physiological basis of motility allows rational pharmacological intervention and helps distinguish between functional and structural etiologies.

Disorder	Pathophysiology	Key Clinical Features	Pharmacological Approach
Achalasia	Loss of inhibitory (NO/VIP) myenteric neurons → LES fails to relax	Dysphagia to solids + liquids, bird's beak on barium swallow, ↑ LES pressure	Botox (↓ ACh at LES), Ca²⁺ channel blockers, nitrates; definitive: myotomy
Gastroparesis	Impaired gastric motility (often vagal neuropathy in DM); ↓ antral contractions	Nausea, vomiting undigested food, early satiety, bloating	Metoclopramide (D₂ antagonist/5-HT₄ agonist, prokinetic), erythromycin (motilin agonist)
Hirschsprung Disease	Congenital absence of ganglion cells (Auerbach + Meissner) in distal colon → tonic contraction	Neonatal failure to pass meconium in 48 hr, abdominal distension, transition zone on barium enema	Surgical resection of aganglionic segment (pull-through procedure)
Dumping Syndrome	Post-vagotomy/gastrectomy: loss of receptive relaxation → rapid gastric emptying of hyperosmolar chyme	Early: cramping, diarrhea, tachycardia after meals; Late: reactive hypoglycemia	Dietary modification (small frequent meals); octreotide (inhibits GI hormones)
Paralytic Ileus	Diffuse inhibition of bowel motility (post-surgical sympathetic activation, electrolyte disturbance)	Absent bowel sounds, abdominal distension, obstipation, diffusely dilated loops on imaging	Correct underlying cause, ambulation, electrolyte correction; neostigmine for acute colonic pseudo-obstruction

High-yield GI motility disorders for USMLE Step 1

💊

CLINICAL PEARL

Prokinetic agents work by enhancing the natural motility machinery. Metoclopramide blocks inhibitory D₂ receptors and stimulates excitatory 5-HT₄ receptors on enteric neurons, effectively 'turning up the volume' on the gut's intrinsic contraction program. Erythromycin directly mimics motilin—the hormone responsible for the migrating motor complex—effectively 'ordering a housekeeping sweep' even outside the fasting period. Understanding these mechanisms explains both their therapeutic uses and their side effects (e.g., metoclopramide crossing the BBB can cause extrapyramidal symptoms via D₂ blockade in the basal ganglia).

SECTION 8

Connection to Advanced Concepts — The Gut–Brain Axis & Beyond

The principles of GI motility discussed thus far provide a foundation for understanding more complex physiological and pathological concepts that bridge gastroenterology with neuroscience, immunology, and endocrinology.

Foundational Concept	Advanced Extension	Clinical Relevance
ENS as 'the little brain'	Gut–brain axis: bidirectional communication via vagus nerve, enteroendocrine signaling, and microbiome-derived metabolites	IBS pathophysiology, visceral hypersensitivity, serotonin-based therapies (alosetron, tegaserod)
ICCs as pacemakers	c-Kit receptor (CD117) expression on ICCs; loss of ICCs in GI stromal tumors (GISTs) and diabetic gastroparesis	Imatinib (c-Kit inhibitor) for GIST; electrogastrography research
Migrating motor complex	Disruption in SIBO: bacterial overgrowth impairs MMC cycling; prokinetics restore housekeeper function	Hydrogen breath testing for SIBO; low-dose erythromycin or prucalopride for MMC restoration
Autonomic modulation	Vagal nerve stimulation for functional GI disorders; neuroimmune interactions (mast cell–nerve cross-talk)	Functional dyspepsia, post-infectious IBS, neuromodulation research

Bridging foundational GI motility concepts to advanced topics

The gut–brain axis represents one of the most rapidly evolving areas in gastroenterology. Approximately 95% of the body's serotonin (5-HT) is produced by enterochromaffin cells in the gut mucosa, and this serotonin modulates both motility and visceral sensation. The vagus nerve carries approximately 80% afferent fibers (gut-to-brain) and only 20% efferent fibers (brain-to-gut), underscoring the gut's massive sensory role. These concepts are increasingly tested on Step 1 in the context of functional GI disorders and the pharmacology of serotonergic agents. As you advance to Step 2 CK and clinical rotations, an understanding of the basic motility framework presented in this lesson will be essential for managing real patients with dysmotility syndromes.

SECTION 9

Practice Problems

Question 1: CONCEPTUAL

A researcher records electrical activity from an isolated segment of small intestinal smooth muscle. She observes rhythmic depolarizations occurring at 12 cycles per minute, but no mechanical contractions are seen. What is the most likely explanation, and what additional event must occur for contraction to take place?

Show answer

The researcher is observing slow waves generated by interstitial cells of Cajal (ICCs). Slow waves represent the basic electrical rhythm of the gut and occur continuously, but they do not cause contraction by themselves. For contraction to occur, the slow wave depolarization must reach threshold, triggering spike potentials (action potentials) that open voltage-gated Ca²⁺ channels and allow calcium influx. Neural input (e.g., ACh from parasympathetic stimulation) or hormonal input is typically required to bring the slow wave above threshold. The 12 cycles/min frequency is characteristic of the duodenum.

Question 2: BASIC CALCULATION

A patient's gastric slow wave frequency is measured at 3 cycles per minute. If a prokinetic agent increases the probability that each slow wave triggers a contraction from 30% to 70%, by what factor does the effective contraction rate increase?

Show answer

The effective contraction rate is the product of slow wave frequency and the probability of contraction. Baseline effective rate = 3 cycles/min × 0.30 = 0.9 contractions/min. After treatment, effective rate = 3 cycles/min × 0.70 = 2.1 contractions/min. The factor of increase = 2.1 ÷ 0.9 ≈ 2.33. Note that the prokinetic agent does not change the slow wave frequency (which is set by the ICCs) but rather increases the likelihood that each slow wave crosses threshold. This illustrates the fundamental principle that slow waves set the maximum contraction rate while neural/hormonal input determines the actual contraction rate.

Question 3: INTERMEDIATE

A 60-year-old man with long-standing type 2 diabetes presents with nausea, vomiting of food eaten 12 hours prior, early satiety, and bloating. An upper endoscopy performed after an overnight fast reveals a large amount of retained gastric contents but no mechanical obstruction. Which specific neural pathway is most likely impaired, and which pharmacological agent targets the hormone that normally initiates fasting motility patterns?

Show answer

This presentation is classic for diabetic gastroparesis. The impaired neural pathway is the vagus nerve, which undergoes progressive neuropathy due to chronic hyperglycemia-induced nerve damage. Vagal impairment disrupts both the vagovagal reflexes needed for receptive relaxation and the coordination of antral contractions for gastric emptying. The hormone that initiates fasting motility patterns (the migrating motor complex) is motilin, released from duodenal M cells. Erythromycin is a motilin receptor agonist that can stimulate gastric contractions and improve emptying. Metoclopramide, a D₂ antagonist and 5-HT₄ agonist, is another prokinetic option but carries risk of extrapyramidal side effects due to central D₂ blockade.

Question 4: APPLIED

A newborn fails to pass meconium within the first 48 hours of life. Abdominal X-ray shows dilated loops of bowel. A barium enema reveals a narrowed distal segment of the rectosigmoid colon with proximal dilation. Rectal biopsy confirms absence of ganglion cells. Explain the pathophysiology of the motility defect, identify which neural plexuses are affected, and predict the physiological consequence for the internal anal sphincter.

Show answer

This is Hirschsprung disease (congenital aganglionic megacolon), resulting from failure of neural crest cell migration during embryonic development. Both the myenteric (Auerbach) plexus and the submucosal (Meissner) plexus are absent in the affected segment. Without inhibitory neurons (those releasing NO and VIP) in the myenteric plexus, the aganglionic segment cannot relax and remains tonically contracted, creating a functional obstruction. The internal anal sphincter, which is smooth muscle, also lacks inhibitory innervation and therefore fails to relax during the rectoanal inhibitory reflex—this is the basis for anorectal manometry testing for Hirschsprung disease. The proximal bowel dilates because it has normal ganglia and is trying to overcome the distal functional obstruction. Treatment requires surgical resection of the aganglionic segment.

Question 5: CRITICAL THINKING

A 45-year-old woman who underwent truncal vagotomy with pyloroplasty for refractory peptic ulcer disease now reports severe postprandial cramping, diarrhea, and diaphoresis occurring 15–30 minutes after eating, as well as episodes of lightheadedness 2–3 hours after meals. Using your knowledge of GI motility physiology, explain the mechanisms behind both the early and late symptoms, and predict the effect of vagotomy on the migrating motor complex.

Show answer

This patient has dumping syndrome following vagotomy with pyloroplasty. The early symptoms (15–30 min postprandially) result from loss of receptive relaxation in the gastric fundus (a vagovagal reflex mediated by VIP/NO) combined with pyloric disruption. Without the ability to accommodate and gradually meter out chyme, the stomach rapidly empties hyperosmolar contents into the small intestine. This causes osmotic fluid shifts into the bowel lumen (producing diarrhea and cramping) and a reflexive autonomic response with catecholamine release (producing diaphoresis and tachycardia). The late symptoms (2–3 hours) represent reactive hypoglycemia: rapid carbohydrate delivery triggers an exaggerated insulin response via the incretin effect (GIP from K cells), leading to a subsequent hypoglycemic nadir. Regarding the MMC, truncal vagotomy disrupts the cephalic phase regulation of motilin release and impairs vagal coordination of Phase III contractions. This predisposes to disordered interdigestive motility and may contribute to small intestinal bacterial overgrowth (SIBO), as the 'housekeeper' function of the MMC is compromised. This case illustrates how a single surgical intervention disrupts multiple interdependent motility mechanisms.

SUMMARY

Summary — Gastrointestinal Physiology and Motility

Summary

GI motility is orchestrated by four interconnected systems. Interstitial cells of Cajal (ICCs) generate slow waves that set the maximum contraction frequency for each GI segment (stomach ~3/min, duodenum ~12/min, ileum ~8–9/min, colon ~2–6/min). Contraction only occurs when slow waves reach threshold and trigger spike potentials, opening Ca²⁺ channels and activating the calmodulin–MLCK contraction cascade. The enteric nervous system (ENS) programs motility patterns through the myenteric (Auerbach) plexus (motility) and submucosal (Meissner) plexus (secretion), using excitatory mediators (ACh, substance P) and inhibitory mediators (NO, VIP). Parasympathetic input (vagus, pelvic nerves) generally promotes motility, while sympathetic input inhibits it.

Regional motility patterns include esophageal peristalsis (with LES relaxation via NO/VIP), gastric receptive relaxation and antral grinding, small intestinal segmentation (fed) and the motilin-driven MMC (fasting), and colonic haustral churning and mass movements. Key reflexes—gastrocolic, gastroileal, intestino-intestinal, and defecation—coordinate inter-segmental motility. High-yield clinical correlations include achalasia (loss of inhibitory neurons), Hirschsprung disease (absent ganglia from neural crest migration failure), gastroparesis (vagal neuropathy), and dumping syndrome (post-vagotomy loss of receptive relaxation). Pharmacologically, metoclopramide (D₂ antagonist/5-HT₄ agonist) and erythromycin (motilin agonist) are key prokinetic agents that leverage the gut's intrinsic motility machinery.